Predictors of response to neoadjuvant treatment and changes to HER2 status in HER2-positive invasive breast cancer
Background and purpose: The response of human epidermal growth factor receptor 2 (HER2)-positive invasive breast cancer to HER2 targeted neoadjuvant therapy is significant. However, the response is not uniform, and a proportion of patients respond poorly. This study aimed to identify predictors of r...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Office of China Oncology
2022-05-01
|
Series: | Zhongguo aizheng zazhi |
Subjects: | |
Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1654759392696-995282893.pdf |